Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.
Hose D, Ray S, Rößler S, Thormann U, Schnettler R, de Veirman K, Khassawna TE, Heiss C, Hild A, Zahner D, Alagboso F, Henss A, Beck S, Emde-Rajaratnam M, Burhenne J, Bamberger J, Menu E, de Bruyne E, Gelinsky M, Kampschulte M, Rohnke M, Wenisch S, Vanderkerken K, Hanke T, Seckinger A, Alt V.
Hose D, et al. Among authors: ray s.
J Hematol Oncol. 2025 Jan 24;18(1):11. doi: 10.1186/s13045-025-01663-9.
J Hematol Oncol. 2025.
PMID: 39856743
Free article.
No abstract available.